Top Quality 99% Anti-Ulcer CAS 90098-04-7 Rebamipide

• Customization: Available
• Powder: Yes
• Customized: Customized
• Model NO.: TGY022019042508
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Adult
• State: Solid
• Purity: >99%
• Product Name: Rebamipide Powder
• Appearance: White Powder
• Specificcation: 99%
• CAS No.: 90098-04-7
• Grade: Pharmaceuticals Grade
• Shelf Life: 2 Years
• Storage: Cool Dry Place
• Shipping Time: Within 3-7 Working Days
• MW: 406.56
• Transport Package: Foil Bag, Box, Drum
• Specification: 99% min
• Trademark: TGY
• Origin: China
• HS Code: 3002200000
• Production Capacity: 1000kg/Month

Product Description

Product name:	Rebamipide
Other Name	(+-)-1,2-dihydro-alpha-((4-chlorobenzoyl)amino)-2-oxo-4-quinolinepropanoica;(+-)-2-(4-chlorobenzoylamino)-3-(2(1h)-quinolinon-4-yl)propionicacid;1,2-dihydro-alpha-((4-chlorobenzoyl)amino)-2-oxo-4-quinolinepropanoicaci(;2-dihydro-alpha-((4-chlorobenzoyl)amino)-2-oxo-(+-)-4-quinolinepropanoicaci;opc12759;opc-12759;Rebamipid;REBAMIPIDE
Original	Made-In-China
CAS	90098-04-7
Molecular formula	C19H15ClN2O4
Appearance	White Powder
Certification	SGS, ISO 9001, KOSHER
Payment Terms	Western Union, Money Gram , T/T, Bitcoin
Minimum Order Quantity	10 g
Price	Negotiable
Usage	It is used for treating stomach ulcers.
Delivery	Fast and secure shipping by EMS, DHL, TNT, FedEx, UPS

_{Prevents and treatment of injury of gastric mucosal caused by NSAIDs
Rebamipide has an obvious reversal effect on the side effects of NSAIDs drug-induced reduction of the synthesis of gastric mucosal prostaglandin and increased permeability of mucosa. Further study has found that patients taking NSAIDs had gotten high expression of gastric epithelial HIF-1, suggesting that the gastric mucosa of patients is within hypoxic-ischemic state; However, patients taking rebamipide has significantly reduced HIF-1 expression, demonstrating that rebamipide has a very good protective effect on the gastric mucosa of patients taking NSAIDs table. From this perspective, rebamipide may have a prevention and treatment effect on NSAIDs (especially non-selective NSAIDs) induced gastric mucosal damage.
 
HP-related gastritis treatment
Rebamipide,Haruma et al have reported that: in the observation of clinical treatment of 86 HP-positive patients, 53 patients taking rebamipide had stomach antrum and stomach body monocytes with significant reduction on granulocytes cell infiltration and had the stomach inflammation much more be alleviated than those without medication, indicating that it has a high-quality effect on treating HP-associated gastritis.} 

Product	Rebamipide
Test items	Standard	Results
Appearance	White crystalline powder, bitter taste	White crystalline
Melting point	About 291ºC(decomposition)	Conforms
Identification	Conforms	290ºC
Loss on drying	≤3.0%	Conforms
Sulphated ash	≤0.10%	1.0%
Assay	99.0%~101.0%	99.2%
Conclusion	The above product conforms to JP6 standard